NeuroBionics

NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. NeuroBionics has developed a technology for minimally-invasive endovascular neuromodulation, to expand access to these lifechanging therapies by significantly reducing the invasiveness of the required surgeries. This tech reduces greenhouse-gas emissions by avoiding resource-intensive manufacturing processes, eliminating the need for clean rooms, avoiding harsh chemicals, and reducing the use of potent greenhouse gases for anesthesia.

• MJ Antonini

  CEO